A TDI (Time Delay and Integration) camera is a high-performance imaging system used in MGI’s T20×2 ultra-high throughput sequencer to capture fluorescence signals with exceptional sensitivity and speed. Unlike conventional cameras that take static images, a TDI camera continuously scans across the sequencing slide, synchronizing image acquisition with sample movement. This technique integrates multiple exposures of the same area over time, significantly boosting signal strength and reducing noise. In the T20*, the TDI line-scan cameras work alongside a liquid-immersion optical lens and a large field-of-view objective to capture more fluorescence data per unit time with higher resolution. The result is faster, more accurate base identification and greater sequencing throughput — a cornerstone technology enabling MGI’s record-breaking data generation efficiency.

T7+ features checkpoint resume technology and proactive fault detection, allowing sequencing to continue without data loss once power or system issues are resolved.

The 7-in-1 integrated workflow minimizes manual intervention—preparation and monitoring are streamlined, so staff can focus on data analysis rather than instrument operation.

Yes. The modular QUAD-Flow Cell system allows independent runs, supporting both small batches and large-scale sequencing without compromising speed or accuracy.

The platform is designed to fit seamlessly into existing operations, with smart guidance, automated data processing, and flexible output formats that simplify downstream analysis.

The T1+ integrates seamlessly into oncology and comprehensive genomic profiling (CGP) pipelines, providing the depth and coverage needed for both solid tumour and liquid biopsy applications. With PE150 read lengths and up to 1.2 Tb per run, it supports multi-sample batching without compromising turnaround time.

Across all flow cell types, >93% of bases exceed Q30 and >90% exceed Q40, ensuring high-confidence variant detection for SNVs, indels, CNVs, and fusions. This level of consistency reduces the need for re-runs and strengthens the reliability of reported results.

Depending on the mode, runs complete within 7–24 hours, with automated secondary analysis available immediately post-run on the T1+ ARS configuration. This supports faster clinical reporting and improved patient turnaround.

The DNB Make & Load module automates DNB preparation within the sequencer, reducing manual steps, contamination risk, and hands-on time. Most labs can run end-to-end sequencing with minimal intervention after library prep.

Yes. Each flow cell operates independently, allowing different read lengths or applications—for example, running oncology panels alongside RNA-Seq or WES on the same instrument without downtime.